n-acetyl cyteien

ApprovedSmall molecule

SStanford University

n-acetyl cyteien is one of 960 small molecule programs targeting Cirrhosis of Liver. It is currently in Approved.

Indications

103

Total Trials

Active Trials

959

Competitors

Pipeline

Status by Indication[3][1]

Indication

Cirrhosis of LiverActive, not recruiting

PoisoningActive, not recruiting

BronchiolitisActive, not recruiting

Uterine LeiomyomaActive, not recruiting

Carpal Tunnel SyndromeActive, not recruiting

ToxicityActive, not recruiting

AnosmiaActive, not recruiting

Cognitive ImpairmentActive, not recruiting

HepatitisActive, not recruiting

ThrombocytopeniaActive, not recruiting

Cirrhosis of LiverPreclinical

Active, not recruiting

PoisoningPhase 1

Active, not recruiting

BronchiolitisApproved

Active, not recruiting

Uterine LeiomyomaPhase 2/Phase 3

Active, not recruiting

Carpal Tunnel SyndromeApproved

Active, not recruiting

ToxicityPreclinical

Active, not recruiting

AnosmiaPhase 1

Active, not recruiting

Cognitive ImpairmentPhase 1/Phase 2

Active, not recruiting

HepatitisApproved

Active, not recruiting

ThrombocytopeniaApproved

Active, not recruiting

Showing 10 of 48 indications

Competition

Competitive Landscape

1931 competitors in COVID-19

#DrugCompanyPhaseTrials

n-acetyl cyteien

SStanford University

Approved

4 2

Angiomax

BBaxter Healthcare Corporation

Preclinical

2 3

Rayaldee

OOrganon and Co

Preclinical

1 4

Aquasol E

NNational Eye Institute (NEI)

Preclinical

1 5

Tricor

JJagotec

Preclinical

1 6

Statin

Bristol-Myers Squibb

Preclinical

1 7

Orap

Teva

Preclinical

1 8

Blood Taken

HHospices Civils de Lyon

Preclinical

1 9

Blood Collection

AAssistance Publique - Hôpitaux de Paris

Preclinical

1 10

Exoflo

DDirect Biologics, LLC

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2026

Phase 3Not yet recruiting

Neonatal Sepsis

NCT07380347

Q4 2026

Post-ApprovalRecruiting

Carpal Tunnel Syndrome

NCT04460521

Post-ApprovalRecruiting

Randomised Controlled Trial

NCT05408247

Phase 3Active, not recruiting

Percutaneous Coronary Intervention

NCT01878669

Q1 2027

Phase 2Active, not recruiting

Multiple Sclerosis

NCT05122559

Q2 2027

Phase 2Not yet recruiting

Cornelia De Lange Syndrome

NCT04381897

Clinical

Trials by Indication[1]

COVID-194 trials

Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19

Terminated·PPrisma Health-Upstate·Phase 1·NCT04545008·2 enrolled

Effect of N-Acetylcysteine on Neutrophil Lymphocyte Ratio And Length of Stay In COVID-19 Patients

Completed·UUniversitas Sebelas Maret·Phase 1/2·NCT05658549·120 enrolled

Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19

Completed·UUnidad Temporal COVID-19 en Centro Citibanamex·N/A·NCT04570254·110 enrolled

Show 1 more trial

Inflammatory Regulation Effect of NAC on COVID-19 Treatment

Unknown status·—·Phase 3·NCT04455243·1,180 enrolled

Poisoning3 trials

Effectiveness of N-acetyl Cysteine, Acetyl L- Carnitine and Medicated Paraffin Oil in Aluminium Phosphide Poisoning

Unknown status·—·Phase 4·NCT04509258·100 enrolled

The Role of N-acetylcysteine as a Novel Adjuvant Treatment in Acute Organophosphorus Pesticide Poisoning

Completed·—·Phase 1·NCT05927259·40 enrolled

Supportive Measures in Treatment of Aluminum Phosphide Poisoning

Completed·—·Phase 4·NCT03879356·44 enrolled

Oxidative Stress3 trials

Antioxidant Use in Diabetes to Reduce Oxidative Stress

Terminated·UUniversity of Maryland, Baltimore·Phase 1·NCT03056014·8 enrolled

Oxidative Stress and Surgical Recovery

Completed·SStanford University·Phase 2·NCT04732000·30 enrolled

The Effect of N-acetylcysteine on Oxidative Stress Status and Iron Overload in Thalassemia Major

Completed·—·Phase 1·NCT04260516·100 enrolled

Autism3 trials

An Open-Label Study of N-Acetyl Cysteine in Children With Autism

Completed·SStanford University·Phase 2·NCT00676195·24 enrolled

A Study of N-Acetyl Cysteine in Children With Autism

Completed·SStanford University·Phase 2·NCT00627705·43 enrolled

Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial

Recruiting·SStanford University·Phase 2/3·NCT05664789·144 enrolled

Schizophrenia2 trials

The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia

Completed·IIndiana University·Phase 4·NCT01339858·60 enrolled

Schizophrenia, Related Troubles and Glutathione: Clinical Trial. Effects of Oral Administration of N-Acetylcysteine (NAC) on the Brain Glutathione Level and on the Symptoms of Schizophrenia

Completed·—·Phase 1·NCT01506765·13 enrolled

76 more indications

Polycystic Ovary Syndrome2 trials

The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients

Recruiting·—·Phase 3·NCT06836128·102 enrolled

N-acetyl Cysteine for Ovulation Induction in Clomiphene Citrate Resistant Polycystic Ovary Syndrome

Completed·—·Phase 4·NCT02239107·70 enrolled

Ototoxicity2 trials

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Unknown status·SSunnybrook Health Sciences Centre·Phase 1/2·NCT04291209·80 enrolled

Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity

Terminated·—·Phase 4·NCT04226456·19 enrolled

Chronic Kidney Disease2 trials

Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3

Completed·—·N/A·NCT05264584·120 enrolled

N-acetyl Cysteine: the Effectiveness and Safety in a Cohort of Pediatric Patients With Chronic Kidney Disease

Completed·—·Phase 2·NCT04916080·50 enrolled

Treatment2 trials

The Use of Oral N-Acetyl Cysteine for the Treatment of Chronic Sinonasal Symptoms

Unknown status·UUniversity of Calgary·Phase 4·NCT00866866·60 enrolled

Defining N-Acetyl Cysteine as a Treatment for Inhibiting Prurogenic Stimuli

Completed·WWright State University·Phase 1·NCT05287724·20 enrolled

Anosmia2 trials

NAC Trial for Anosmia

Completed·UUniversity of Miami·Phase 1·NCT02481609·29 enrolled

NAC for Head Trauma-induced Anosmia

Terminated·UUniversity of Miami·Phase 3·NCT03680911·7 enrolled

Function2 trials

Combination of Vitamin C and N-Acetylcysteine to Improve Functional Outcome After Rotator Cuff Repair

Not yet recruiting·MMahidol University·Phase 4·NCT06384833·110 enrolled

N-Acetyl Cysteine Effect on Liver Function After Mitral Valve Replacement

Completed·KKasr El Aini Hospital·Phase 4·NCT06486805·54 enrolled

Hepatitis2 trials

N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis

Unknown status·IImperial College London·Phase 3·NCT03069300·42 enrolled

Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis

Recruiting·MMahidol University·Phase 4·NCT06484530·116 enrolled

Acute Kidney Injury2 trials

Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement

Unknown status·UUniversity of Sao Paulo General Hospital·Phase 4·NCT03440268·154 enrolled

Vitamin E and N-acetylcysteine for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization

Unknown status·RRajaie Cardiovascular Medical and Research Center·Phase 3·NCT03755700·1,000 enrolled

Epilepsy2 trials

the Safety and Efficacy of N-acetyl Cysteine in Children With Drug-Resistant Epilepsy

Completed·TTanta University·Phase 2·NCT05485558·90 enrolled

Treatment Resistant Epilepsy and N-Acetyl Cysteine

Withdrawn·NNationwide Children's Hospital·N/A·NCT02054949

Oral Mucositis2 trials

Effect of N-acetyl Cysteine and Zinc in Management of Head and Neck Cancer Radiotherapy Induced Oral Mucositis

Completed·MMansoura University·Phase 2·NCT06482034·50 enrolled

N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation.

Unknown status·Mmoshe yeshurun·Phase 3·NCT04756622·116 enrolled

Lung Disease1 trial

A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease

Recruiting·TThe Aurum Institute NPC·N/A·NCT06909799·242 enrolled

Veterans1 trial

GWICTIC: NAC Mechanistic Study in Gulf War Veterans

Recruiting·NNova Southeastern University·Phase 1·NCT04987775·170 enrolled

Calcium Hydroxide1 trial

Comparison of the Effects of N-acetylcysteine, Calcium Hydroxide, and Double Antibiotic Paste

Completed·—·N/A·NCT07340944·45 enrolled

Toxicity1 trial

Impact of N-acetylcysteine Infusion and Intralipid Infusion on Myocardial Injury in Aluminum Phosphide Toxicity

Unknown status·—·N/A·NCT05370729·58 enrolled

Depressive Symptoms1 trial

N-acetylcysteine in the Treatment of Depressive Symptoms in Bipolar Offspring

Unknown status·UUniversity of Cincinnati·N/A·NCT02865629·22 enrolled

Drug-Induced Liver Injury1 trial

Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial

Unknown status·MMahidol University·Phase 2/3·NCT05738681·82 enrolled

Cornelia de Lange syndrome1 trial

Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome

Not yet recruiting·JJohns Hopkins University·Phase 2·NCT04381897·10 enrolled

Randomised Controlled Trial1 trial

A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder

Recruiting·UUniversity of Sydney·Phase 4·NCT05408247·280 enrolled

Withdrawal1 trial

The Efficacy of N-acetylcysteine Versus Placebo for the Treatment of Metamphetamine Withdrawal Symptoms

Completed·MMelva Louisa·Phase 2/3·NCT04405193·66 enrolled

Skin1 trial

N-Acetyl Cysteine in Pathologic Skin Picking

Completed·UUniversity of Chicago·Phase 2·NCT01063348·66 enrolled

Tuberculosis1 trial

Comparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous Drugs for Tuberculosis at a Tertiary Care Hospital , Karachi

Not yet recruiting·LLiaquat National Hospital & Medical College·Phase 1·NCT07058090·410 enrolled

Vitamin D1 trial

Evaluation of the Role of N Acetyl Cysteine and Vitamin D in Improving Outcomes After Corrosive Ingestion

Active, not recruiting·—·Phase 3·NCT07229456·80 enrolled

Influenza1 trial

Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia

Unknown status·—·Phase 3·NCT03900988·160 enrolled

Niemann-Pick disease1 trial

Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine

Completed·EEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)·Phase 1/2·NCT00975689·35 enrolled

Brain Injury1 trial

The Use of Anti-oxidants to Reduce Sequela of Mild Traumatic Brain Injury (mTBI) After Blast Exposure

Completed·—·N/A·NCT00822263·150 enrolled

Endometrioma1 trial

NAC Effect on Infertile Women With Endometrioma

Unknown status·RRoyan Institute·Phase 3·NCT05460858·140 enrolled

Fatigue1 trial

A Study of Oxidative Pathways in MS Fatigue

Completed·UUniversity of California, San Francisco·Phase 2·NCT02804594·15 enrolled

Alcohol Effect1 trial

Influence of n-Acetylcysteine Maintenance on Alcohol Effects

Completed·WWilliam Stoops·Phase 1·NCT03216954·14 enrolled

Colorectal Cancer1 trial

Protective Effect of N-acetylcysteine on Oxaliplatin-Induced Neuropathy in Colorectal Cancer

Completed·TTanta University·N/A·NCT07391163·46 enrolled

Thrombocytopenia1 trial

Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients

Completed·HHelwan University·Phase 4·NCT05944458·250 enrolled

Injury1 trial

Signatures of N-Ac for Non-Suicidal Self-Injury in Adolescents

Completed·UUniversity of Minnesota·Phase 2·NCT04005053·44 enrolled

Intravenous1 trial

Intravenous NAC Use in ACLF Patients

Unknown status·—·N/A·NCT05089981·100 enrolled

Geriatric Patients1 trial

Prospective Analysis of the Use of N-Acetylcysteine and Vitamins in the Treatment of TBI in Geriatric Patients

Completed·HHonorHealth Research Institute·Phase 2·NCT04291066·92 enrolled

Pathological Gambling1 trial

An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling

Completed·UUniversity of Minnesota·Phase 1·NCT00273702·36 enrolled

Necrotizing Enterocolitis1 trial

Effect of Oral N-Acetyl Cysteine in Prevention of Necrotizing Enterocolitis in Preterm Neonates With Feeding Intolerance

Unknown status·—·Phase 4·NCT06202911·100 enrolled

Neonatal sepsis1 trial

Effect of N-acetylcysteine as Adjunct Therapy on the Clinical Outcome of Neonatal Sepsis

Not yet recruiting·—·Phase 3·NCT07380347·50 enrolled

Biliary Atresia1 trial

N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy

Completed·—·Phase 2·NCT03499249·13 enrolled

Atopic Dermatitis1 trial

Comparison Between Topical N-acetyl Cysteine (NAC) in Cold Cream Versus Cold Cream in Mild and Moderate Atopic Dermatitis: Clinical and Bacteriological Evaluation. A Randomized Control Trial.

Completed·—·N/A·NCT07323719·100 enrolled

Biomarkers1 trial

Study of the Effect of N-acetyl Cysteine on the Renal Graft Function Biomarkers (IL18, NGAL)

Unknown status·SShahid Beheshti University of Medical Sciences·Phase 3·NCT01403506·60 enrolled

Stem Cells1 trial

N-Acetyl Cysteine Protects Pulpal Stem Cells in Endodontic Revascularization

Terminated·UUniversity of California, Los Angeles·Phase 1·NCT03451435·7 enrolled

Bronchiolitis1 trial

Nebulized N-Acetyl Cysteine for Bronchiolitis in Inpatient Hospital Use

Unknown status·CCarilion Clinic·Phase 4·NCT03364218·106 enrolled

NAC1 trial

The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation

Not yet recruiting·MMassachusetts General Hospital·Phase 1·NCT07323446·120 enrolled

ESS1 trial

NAC Effect on Hox Genes Expressions in RIF

Completed·RRoyan Institute·Phase 3·NCT03862586·40 enrolled

Multiple Sclerosis1 trial

Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis

Active, not recruiting·—·Phase 2·NCT05122559·98 enrolled

Carpal Tunnel Syndrome1 trial

The ACTS Trial: N-acetylcysteine (NAC) and Night-splinting as a Non-operative Treatment for Carpal Tunnel Syndrome

Recruiting·EEmily Krauss·Phase 4·NCT04460521·240 enrolled

Prospective1 trial

Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial

Completed·FFernando J Martinez·Phase 3·NCT04300920·202 enrolled

Neurofibromatosis Type 11 trial

Antioxidant Therapy With N-acetylcysteine for Children With Neurofibromatosis Type 1

Active, not recruiting·—·Phase 2·NCT04481048·58 enrolled

Periodontitis1 trial

Chlorhexidine Versus N-Asetil Sistein Irrigation in Mandibular Molar Teeth with Chronic Apical Periodontitis

Completed·—·N/A·NCT06834711·78 enrolled

Pancreatitis1 trial

Comparative Clinical Study to Evaluate the Possible Efficacy and Safety of Oral N-Acetyl Cysteine Versus Rectal Diclofenac in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis

Completed·TTanta University·Phase 1/2·NCT06252441·46 enrolled

Percutaneous Coronary Intervention1 trial

Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention

Active, not recruiting·SSuleyman Demirel University·Phase 3·NCT01878669·390 enrolled

Cycling1 trial

Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 1H-MRS

Completed·YYale University·Phase 1·NCT02124941·6 enrolled

Cannabis Use Disorder1 trial

N-Acetylcysteine for Youth Cannabis Use Disorder

Completed·MMedical University of South Carolina·Phase 2/3·NCT03055377·192 enrolled

Stroke1 trial

N-ACETYLCYSTEINE FOR THROMBOLYSIS IN ACUTE STROKE

Terminated·UUniversity Hospital, Caen·Phase 2·NCT04920448·12 enrolled

Tics1 trial

Microbiological Characteristics of Biofilm on Double J Ureteral Stents After Lithotripsy.

Not yet recruiting·MMenoufia University·Phase 4·NCT07301294·100 enrolled

Oral1 trial

N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers

Completed·UUniversity of Chicago·Phase 2·NCT00967005·28 enrolled

Acute Respiratory Distress Syndrome1 trial

N-Acetyl-cysteine in Early Acute Respiratory Distress Syndrome

Withdrawn·PPrisma Health-Midlands·Phase 1·NCT03346681

Intracanal Medicament1 trial

Effect of N-acetylcysteine Versus Calcium Hydroxide Used as an Intracanal Medicament on the Intensity of Postoperative Pain, Bacterial Load Reduction and Levels of MMP -9 in Periapical Fluids in Patients With Necrotic Pulp

Unknown status·—·Phase 1·NCT05666089·30 enrolled

Uterine leiomyoma1 trial

Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma

Completed·—·Phase 2/3·NCT06115408·40 enrolled

Trichotillomania1 trial

N-Acetyl Cysteine in Trichotillomania

Completed·UUniversity of Chicago·Phase 2·NCT00354770·50 enrolled

Cervical Cerclage1 trial

N-Acetyl Cysteine After Cervical Cerclage

Completed·—·N/A·NCT00787813·100 enrolled

Cognitive impairment1 trial

Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT

Not yet recruiting·UUniversity of California, Irvine·Phase 1/2·NCT04520139·102 enrolled

Cystinosis1 trial

N Acetyl Cysteine for Cystinosis Patients

Completed·UUniversity of Sao Paulo·Phase 4·NCT01614431·23 enrolled

Toxicities1 trial

Evaluation of the Effect of N-acetylcysteine in Preventing Cisplatin-Induced Toxicities in Cancer Patients

Unknown status·—·Phase 2·NCT06297369·60 enrolled

Pulmonary Tuberculosis1 trial

Adjunctive NAC in Adult Patients With Pulmonary Tuberculosis

Completed·TThe Aurum Institute NPC·Phase 2·NCT03702738·110 enrolled

Nephropathy1 trial

Ameliorating Contrast Induced Nephropathy After Coronary Angiography

Completed·—·Phase 4·NCT06139952·120 enrolled

Bacterial Vaginosis1 trial

Role of N-Acetylcysteine in Treatment of Bacterial Vaginosis

Unknown status·MMinia University·Phase 4·NCT01841411·90 enrolled

Cirrhosis of Liver1 trial

N-Acetyl Cysteine in the Prevention of Contrast Induced Nephropathy in Cirrhosis of Liver-NEPHRO Trial

Completed·IInstitute of Liver and Biliary Sciences, India·N/A·NCT03759158·100 enrolled

Bipolar Disorder1 trial

Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder

Completed·MMedical University of South Carolina·Phase 2·NCT05340504·12 enrolled

Smoking Cessation1 trial

N-Acetylcysteine for Smoking Cessation in Tobacco and Cannabis Co-Use

Completed·EEllen Herbst·Phase 4·NCT04627922·59 enrolled

PCOS1 trial

NAC in CC Resistant PCOS After LOD

Completed·—·Phase 2/3·NCT02775734·144 enrolled

Type 1 Diabetes1 trial

A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes

Completed·UUniversity of Minnesota·Phase 1/2·NCT02206152·22 enrolled

Cannabis Use1 trial

Marijuana Cue-Reactivity & Seeking Behavior in Regular Cannabis Users

Completed·WWayne State University·Phase 1·NCT03154580·21 enrolled

Hematopoietic Stem Cell Transplantation1 trial

The Use of N-acetylcysteine for Thrombotic Events After Allogenic Hematopoietic Stem Cell Transplantation

Unknown status·TThe First Affiliated Hospital of Soochow University·Phase 3·NCT05907486·260 enrolled

Chronic Thromboembolic Pulmonary Hypertension1 trial

N-acetyl Cysteine in Post-reperfusion Pulmonary Injury in Chronic Thromboembolic Pulmonary Hypertension.

Unknown status·IInstituto Nacional de Cardiologia Ignacio Chavez·N/A·NCT04081012·34 enrolled

Bipolar Depression1 trial

Brain Imaging to Understand the Role of Inflammation in N-Acetyl Cysteine (NAC) Treatment of Bipolar Depression

Completed·MMartin Lan·Phase 1·NCT03730064·3 enrolled

Unspecified3 trials

The FIGHT-RP1 Study

Completed·JJohns Hopkins University·Phase 1·NCT03063021·30 enrolled

Glutathione Levels and Compulsivity

Completed·UUniversity of Oxford·N/A·NCT02794389·23 enrolled

A Pan-TB Regimen Targeting Host and Microbe

Active, not recruiting·TThe Aurum Institute NPC·Phase 2/3·NCT05686356·352 enrolled

Sources

References

[1]
ClinicalTrials.gov — 103 trial records for n-acetyl cyteien. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — n-acetyl cyteien compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for n-acetyl cyteien. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Stanford University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: SStanford University